The Clinical Trial Grant Program has announced its research grants to support academic-industry partnerships and MND researchers developing Phase II or III clinical trials of novel treatments to advance translational research into motor neurone disease. Proposals must be for one Phase II or Phase III clinical treatment trial of a novel drug or drug combination,
Access Restricted: Members-Only Content. We're sorry, but this content is available exclusively to our subscribed members: